{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:47Z","timestamp":1786982207397,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s12033-021-00382-z","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T14:05:38Z","timestamp":1629900338000},"page":"25-32","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Clinical Significance and Functional Role of miR-466 in Gastric Cancer Peritoneal Metastasis"],"prefix":"10.1007","volume":"64","author":[{"given":"Yong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3984-963X","authenticated-orcid":false,"given":"Pingli","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,25]]},"reference":[{"key":"382_CR1","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1158\/1055-9965.EPI-13-1057","volume":"23","author":"P Karimi","year":"2014","unstructured":"Karimi, P., Islami, F., Anandasabapathy, S., Freedman, N. D., & Kamangar, F. (2014). Gastric cancer: Descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiology, Biomarkers & Prevention, 23, 700\u2013713.","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"382_CR2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani, C., Matsuda, T., Di Carlo, V., et al. (2018). Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet (London, England)., 391, 1023\u20131075.","journal-title":"Lancet (London, England)."},{"key":"382_CR3","first-page":"1576","volume":"8","author":"D Wu","year":"2019","unstructured":"Wu, D., Zhang, P., Ma, J., et al. (2019). Serum biomarker panels for the diagnosis of gastric cancer, 8, 1576\u20131583.","journal-title":"Serum biomarker panels for the diagnosis of gastric cancer"},{"key":"382_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40880-017-0206-7","volume":"36","author":"CN Qian","year":"2017","unstructured":"Qian, C. N., Mei, Y., & Zhang, J. (2017). Cancer metastasis: Issues and challenges. Chinese Journal of Cancer., 36, 38.","journal-title":"Chinese Journal of Cancer."},{"key":"382_CR5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.28373","volume":"134","author":"I Thomassen","year":"2014","unstructured":"Thomassen, I., van Gestel, Y. R., van Ramshorst, B., et al. (2014). Peritoneal carcinomatosis of gastric origin: A population-based study on incidence, survival and risk factors. International Journal of Cancer., 134, 622\u2013628.","journal-title":"International Journal of Cancer."},{"key":"382_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrg2843","volume":"11","author":"J Krol","year":"2010","unstructured":"Krol, J., Loedige, I., & Filipowicz, W. (2010). The widespread regulation of microRNA biogenesis, function and decay. Nature Reviews Genetics., 11, 597\u2013610.","journal-title":"Nature Reviews Genetics."},{"key":"382_CR7","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"TX Lu","year":"2018","unstructured":"Lu, T. X., & Rothenberg, M. E. (2018). MicroRNA. The Journal of Allergy and Clinical Immunology., 141, 1202\u20131207.","journal-title":"The Journal of Allergy and Clinical Immunology."},{"key":"382_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jbior.2014.09.013","volume":"57","author":"M Acunzo","year":"2015","unstructured":"Acunzo, M., Romano, G., Wernicke, D., & Croce, C. M. (2015). MicroRNA and cancer: A brief overview. Advances in Biological Regulation., 57, 1\u20139.","journal-title":"Advances in Biological Regulation."},{"key":"382_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole, R., & Slack, F. J. (2017). MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases. Nature Reviews Drug Discovery., 16, 203\u2013222.","journal-title":"Nature Reviews Drug Discovery."},{"key":"382_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/emmm.201100209","volume":"4","author":"MV Iorio","year":"2012","unstructured":"Iorio, M. V., & Croce, C. M. (2012). MicroRNA dysregulation in cancer: Diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Molecular Medicine, 4, 143\u2013159.","journal-title":"EMBO Molecular Medicine"},{"key":"382_CR11","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.7150\/thno.11543","volume":"5","author":"G Bertoli","year":"2015","unstructured":"Bertoli, G., Cava, C., & Castiglioni, I. (2015). MicroRNAs: New biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics., 5, 1122\u20131143.","journal-title":"Theranostics."},{"key":"382_CR12","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.2217\/pgs-2017-0010","volume":"18","author":"JR Puik","year":"2017","unstructured":"Puik, J. R., Meijer, L. L., Le Large, T. Y., et al. (2017). miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma. Pharmacogenomics, 18, 1343\u20131358.","journal-title":"Pharmacogenomics"},{"key":"382_CR13","doi-asserted-by":"publisher","first-page":"7429","DOI":"10.2147\/OTT.S178151","volume":"11","author":"H Yu","year":"2018","unstructured":"Yu, H., Wei, W., Cao, W., et al. (2018). Regulation of cell proliferation and metastasis by microRNA-593-5p in human gastric cancer. OncoTargets and Therapy., 11, 7429\u20137440.","journal-title":"OncoTargets and Therapy."},{"key":"382_CR14","first-page":"153","volume":"17","author":"KT Yuan","year":"2018","unstructured":"Yuan, K. T., & Li, B. X. (2018). Deregulation of microRNA-375 inhibits proliferation and migration in gastric cancer in association with autophagy-mediated AKT\/mTOR. Signaling Pathways, 17, 153.","journal-title":"Signaling Pathways"},{"key":"382_CR15","first-page":"4602","volume":"16","author":"Y Feng","year":"2018","unstructured":"Feng, Y., Bai, F., You, Y., et al. (2018). Dysregulated microRNA expression profiles in gastric cancer cells with high peritoneal metastatic potential. Experimental and Therapeutic Medicine, 16, 4602\u20134608.","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"4","key":"382_CR16","doi-asserted-by":"publisher","first-page":"e1533","DOI":"10.1002\/wrna.1533","volume":"10","author":"JR Iacona","year":"2019","unstructured":"Iacona, J. R., & Lutz, C. S. (2019). miR-146a-5p: Expression, regulation, and functions in cancer. Wiley interdisciplinary reviews. RNA, 10(4), e1533.","journal-title":"Wiley interdisciplinary reviews. RNA"},{"key":"382_CR17","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.prp.2018.09.026","volume":"214","author":"L Zhu","year":"2018","unstructured":"Zhu, L., Deng, H., Hu, J., et al. (2018). The promising role of miR-296 in human cancer. Pathology, Research and Practice, 214, 1915\u20131922.","journal-title":"Pathology, Research and Practice"},{"key":"382_CR18","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.2147\/OTT.S193097","volume":"12","author":"N Li","year":"2019","unstructured":"Li, N., Cui, T., Guo, W., Wang, D., & Mao, L. (2019). MiR-155-5p accelerates the metastasis of cervical cancer cell via targeting TP53INP1. OncoTargets and Therapy., 12, 3181\u20133196.","journal-title":"OncoTargets and Therapy."},{"key":"382_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3233\/CBM-182171","volume":"24","author":"MH Sahami-Fard","year":"2019","unstructured":"Sahami-Fard, M. H., Kheirandish, S., & Sheikhha, M. H. (2019). Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance. Cancer Biomarkers., 24, 291\u2013297.","journal-title":"Cancer Biomarkers."},{"key":"382_CR20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10238-019-00574-7","volume":"19","author":"Y Mytsyk","year":"2019","unstructured":"Mytsyk, Y., Borys, Y., Tumanovska, L., et al. (2019). MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma. Clinical and Experimental Medicine, 19, 515\u201324.","journal-title":"Clinical and Experimental Medicine"},{"key":"382_CR21","doi-asserted-by":"crossref","first-page":"101042831770620","DOI":"10.1177\/1010428317706207","volume":"39","author":"J Zheng","year":"2017","unstructured":"Zheng, J., Ge, P., Liu, X., et al. (2017). MiR-136 inhibits gastric cancer-specific peritoneal metastasis by targeting HOXC10. Tumour Biology, 39, 1010428317706207.","journal-title":"Tumour Biology"},{"key":"382_CR22","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.3892\/or.2016.4985","volume":"36","author":"C Gong","year":"2016","unstructured":"Gong, C., Yang, Z., Wu, F., et al. (2016). miR-17 inhibits ovarian cancer cell peritoneal metastasis by targeting ITGA5 and ITGB1. Oncology Reports, 36, 2177\u20132183.","journal-title":"Oncology Reports"},{"key":"382_CR23","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1080\/15384101.2020.1749467","volume":"19","author":"M Zhu","year":"2020","unstructured":"Zhu, M., Zhang, N., He, S., & Lu, X. (2020). Exosomal miR-106a derived from gastric cancer promotes peritoneal metastasis via direct regulation of Smad7. Cell Cycle (Georgetown, Tex)., 19, 1200\u20131221.","journal-title":"Cell Cycle (Georgetown, Tex)."},{"key":"382_CR24","doi-asserted-by":"publisher","first-page":"651","DOI":"10.21873\/cgp.20221","volume":"17","author":"UH Weidle","year":"2020","unstructured":"Weidle, U. H., Ausl\u00c4nder, S., & Brinkmann, U. (2020). Micro RNAs promoting growth and metastasis in preclinical in vivo models of subcutaneous melanoma. Cancer Genomics & Proteomics., 17, 651\u2013667.","journal-title":"Cancer Genomics & Proteomics."},{"key":"382_CR25","first-page":"2036","volume":"25","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Lv, F., Qiao, L., & Zhao, Q. (2020). MiR-505 inhibits prostate cancer cell invasion, metastasis and epithelial-to-mesenchymal transition through targeting HMGB-1. Journal of BUON, 25, 2036\u20132044.","journal-title":"Journal of BUON"},{"key":"382_CR26","doi-asserted-by":"publisher","first-page":"252","DOI":"10.17305\/bjbms.2018.2376","volume":"18","author":"F Tong","year":"2018","unstructured":"Tong, F., Ying, Y., Pan, H., et al. (2018). MicroRNA-466 (miR-466) functions as a tumor suppressor and prognostic factor in colorectal cancer (CRC). Bosnian Journal of Basic Medical Sciences, 18, 252\u2013259.","journal-title":"Bosnian Journal of Basic Medical Sciences"},{"key":"382_CR27","first-page":"3890","volume":"40","author":"C Jia","year":"2018","unstructured":"Jia, C., Tang, D., Sun, C., et al. (2018). MicroRNA-466 inhibits the aggressive behaviors of hepatocellular carcinoma by directly targeting metadherin. Oncology Reports, 40, 3890\u20133898.","journal-title":"Oncology Reports"},{"key":"382_CR28","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1038\/cddis.2017.15","volume":"8","author":"M Colden","year":"2017","unstructured":"Colden, M., Dar, A. A., Saini, S., et al. (2017). MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2. Cell Death & Disease, 8, 2572.","journal-title":"Cell Death & Disease"},{"key":"382_CR29","first-page":"3345","volume":"19","author":"Y Sun","year":"2019","unstructured":"Sun, Y., Zhou, J., Shi, L., Li, J., & Chen, J. (2019). MicroRNA-466 inhibits cell proliferation and invasion in osteosarcoma by directly targeting insulin receptor substrate 1. Molecular Medicine Reports, 19, 3345\u20133352.","journal-title":"Molecular Medicine Reports"},{"key":"382_CR30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1245\/s10434-019-07624-0","volume":"27","author":"L Ji","year":"2020","unstructured":"Ji, L., Selleck, M. J., Morgan, J. W., et al. (2020). Gastric cancer peritoneal carcinomatosis risk score. Annals of Surgical Oncology., 27, 240\u2013247.","journal-title":"Annals of Surgical Oncology."},{"key":"382_CR31","first-page":"5117","volume":"16","author":"W Cao","year":"2018","unstructured":"Cao, W., Fang, L., Teng, S., Chen, H., & Liu, T. (2018). MicroRNA-466 inhibits osteosarcoma cell proliferation and induces apoptosis by targeting CCND1. Experimental and Therapeutic Medicine., 16, 5117\u20135122.","journal-title":"Experimental and Therapeutic Medicine."}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-021-00382-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-021-00382-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-021-00382-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T07:08:21Z","timestamp":1642230501000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-021-00382-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,25]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["382"],"URL":"https:\/\/doi.org\/10.1007\/s12033-021-00382-z","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,25]]},"assertion":[{"value":"18 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The participant has consented to the submission of the journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"This study was approved by the Ethics Committee of Shanghai Punan Hospital of Pudong New District.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}}]}}